Home › Guides › Thyroid and menopause

Thyroid and menopause — the overlap that is constantly missed

Fatigue, brain fog, weight gain, cold intolerance, hair thinning, low mood. These are hypothyroid symptoms. They are also perimenopause symptoms. The overlap is so complete that women are frequently misdiagnosed — treated for menopause when they have thyroid disease, or dismissed with menopause when they have undiagnosed Hashimoto's. Rose covers the full picture and how to get the right diagnosis.

Rose

"The thyroid-menopause overlap is one of the most consequential diagnostic blind spots I have found in my research. Women spend months or years attributing thyroid symptoms to menopause — or having their thyroid symptoms dismissed because a TSH came back 'normal' — when free T3, free T4, and TPO antibodies would tell a completely different story. The doctor conversation guides for this one matter particularly: you may need to ask specifically for the right tests."

The misdiagnosis problem in numbers

10x

more common in women than men — thyroid disease is fundamentally a women's health issue

40-60

the peak incidence years for Hashimoto's — exactly the perimenopausal window

50%

of women with Hashimoto's are undiagnosed — because TSH alone misses the early disease

The symptom overlap — almost complete

This is why the misdiagnosis runs in both directions. Both conditions must be considered when either is suspected.

Symptom	Hypothyroidism	Perimenopause
Fatigue and exhaustion	✓ Core symptom	✓ Core symptom
Brain fog and poor concentration	✓ Core symptom	✓ Core symptom
Low mood and depression	✓ Core symptom	✓ Core symptom
Weight gain	✓ Core symptom	✓ Core symptom
Cold intolerance	✓ Core symptom	✓ Occurs (post-flash chills)
Sleep disruption	✓ Common	✓ Core symptom
Dry skin and hair	✓ Core symptom	✓ Common
Hair thinning or loss	✓ Core symptom	✓ Common
Constipation	✓ Core symptom	✓ Common
Palpitations	✓ Hyperthyroid (not hypo)	✓ Common
Anxiety	✓ Hyperthyroid primarily	✓ Core symptom
Irregular periods	✓ Common	✓ Core symptom

Why thyroid disease peaks at menopause — five mechanisms

🔄

Why thyroid disorders peak at exactly the menopausal age

Autoimmune thyroid disease — primarily Hashimoto's thyroiditis — is the most common cause of hypothyroidism in women and has a peak incidence at 40-60 years. The perimenopausal years are a period of immune dysregulation: the hormonal changes alter T-cell function and immune tolerance, making autoimmune conditions more likely to emerge or worsen. Women who had subclinical Hashimoto's (positive antibodies, normal TSH) through their 30s may find the disease becomes clinically significant at perimenopause as immune tolerance shifts.

🧬

Estrogen modulates thyroid hormone production and metabolism

Estrogen increases the production of thyroxine-binding globulin (TBG) — the protein that carries thyroid hormones in the bloodstream. More TBG means more thyroid hormone is bound and inactive, reducing free thyroid hormone availability. This is why women on oral estrogen (not transdermal) may need higher thyroid medication doses — the additional TBG binds more levothyroxine. Conversely, falling estrogen at menopause reduces TBG — which can unmask thyroid insufficiency or change the required levothyroxine dose for women already on treatment.

⚡

TSH alone misses the clinical picture in perimenopause

The standard thyroid test is TSH. But TSH is a pituitary signal — it tells you what the pituitary is asking for, not what the tissues are actually getting. Free T3 (the biologically active thyroid hormone) and free T4 (the storage form) reflect what is actually available at tissue level. Many perimenopausal women have TSH within the standard reference range (0.5-4.5 µU/mL) but free T3 in the lower quartile — enough thyroid hormone to suppress TSH feedback, but not enough to resolve symptoms. TSH alone is insufficient for the perimenopausal woman with thyroid symptoms.

🔥

Subclinical hypothyroidism — the grey zone that matters

Subclinical hypothyroidism is defined as TSH above the upper limit of normal with free T4 still within range. It affects 10-15% of women over 45. Symptoms can be identical to hypothyroidism but milder — and are also identical to perimenopause. The key question is whether treatment improves quality of life, particularly when symptoms are significant. Many guidelines recommend treatment when TSH is above 10 µU/mL, or above 4.5 with symptoms. In perimenopausal women, the symptom overlap makes a lower treatment threshold worth considering.

💊

Hashimoto's — the antibody question

Hashimoto's thyroiditis is diagnosed by the presence of TPO (thyroid peroxidase) antibodies or TG (thyroglobulin) antibodies alongside the clinical picture. TPO antibodies can be positive for years or decades before TSH becomes abnormal — the immune attack is ongoing but thyroid reserve compensates. In perimenopause, this compensation may fail — and a previously antibody-positive, TSH-normal woman may transition to overt hypothyroidism. Testing antibodies identifies women at risk before their TSH rises.

The right tests — what to request and what optimal means

Test	Optimal target	Why it matters
TSH	0.5–2.5 µU/mL optimal	The standard screen. But TSH within the standard lab range (0.5-4.5) does not rule out suboptimal thyroid function. Request the number — not just "normal."
Free T4	Upper half of reference range	The storage form of thyroid hormone. Should be in the upper half of the reference range for women with thyroid symptoms — not just anywhere within range.
Free T3	Upper half of reference range	The active thyroid hormone. Often not done on standard panels — request specifically. Many women with symptoms have TSH and T4 normal but free T3 in the lower quartile.
TPO antibodies	Negative (<34 IU/mL)	Diagnoses Hashimoto's — positive years before TSH rises. All perimenopausal women with thyroid symptoms should have this tested once.
TG antibodies	Negative (<115 IU/mL)	Additional Hashimoto's antibody. Less sensitive than TPO but useful when TPO is negative and Hashimoto's is suspected.
Reverse T3 (rT3)	Below 25 ng/dL	Elevated rT3 blocks T3 receptors — producing functional hypothyroidism even when TSH and T4 are normal. Associated with chronic stress and cortisol excess — relevant in perimenopausal HPA dysregulation.

⚠️

The TSH-alone problem

A TSH between 0.5 and 4.5 µU/mL is reported as "normal" by most UK laboratories. But a TSH of 3.8 with free T3 in the lowest quartile of the reference range and positive TPO antibodies is a very different clinical situation from a TSH of 1.2 with all parameters optimal. The number alone is not the diagnosis. Ask for the full panel — TSH, free T4, free T3, and TPO antibodies. Ask for the actual numbers, not just whether they are "normal."

What actually helps — evidence graded

💊

Levothyroxine (T4) — standard thyroid replacement

Strong evidence

Levothyroxine is the standard treatment for hypothyroidism — synthetic T4 that converts to T3 in the body. It is effective for most women and well tolerated. The goal is not just to normalise TSH but to achieve a TSH in the optimal range (0.5-2.5) with free T4 in the upper half of range and resolution of symptoms. Many women are undertreated — their TSH is "within range" but they remain symptomatic because their TSH target and dose have not been optimised.

Key points

• Restores thyroid hormone levels — directly addressing the metabolic, cognitive, and mood deficits of hypothyroidism

• Optimising to TSH 0.5-2.5 rather than just "within range" makes a meaningful symptomatic difference for many women

• Weight, fatigue, brain fog, and cold intolerance typically improve within 6-12 weeks of adequate dosing

• Women on oral estrogen (not transdermal) may need higher doses due to TBG increase — transdermal estrogen avoids this

How to use this

Take on an empty stomach 30-60 minutes before food, coffee, or other medications. Calcium, iron, and many supplements impair absorption — separate by 4 hours. Retest TSH, free T4, and free T3 6-8 weeks after any dose change. Aim for TSH 0.5-2.5, free T4 upper half of range, free T3 upper half of range. If switching from oral to transdermal HRT, recheck thyroid levels — dose requirement may change.

⚡

T4+T3 combination therapy — for women who don't respond fully to T4 alone

Moderate evidence

Some women convert T4 to T3 poorly due to genetic variations in deiodinase enzymes (the enzymes that convert T4 to active T3). Despite normal TSH and T4 on levothyroxine, they have persistently low free T3 and ongoing symptoms. For these women, adding T3 (liothyronine) or switching to desiccated thyroid extract (which contains both T4 and T3) can significantly improve symptom resolution.

Key points

• Addresses poor T4-to-T3 conversion — relevant in women with DIO2 polymorphisms

• Significant improvement in cognitive function, fatigue, and mood in women who remain symptomatic on T4 alone

• Desiccated thyroid extract (Armour Thyroid, Nature-Throid) provides natural T4/T3 in 4:1 ratio

• Can be trialled for 3-6 months to assess response before committing long-term

How to use this

Discuss with an endocrinologist or thyroid-experienced GP. Liothyronine (T3) is prescribed less commonly than levothyroxine — it requires more careful monitoring and more frequent dosing (shorter half-life). Desiccated thyroid extract requires private prescription in the UK but is widely available in the US. Not appropriate for women with heart conditions due to T3's cardiac effects.

🌿

Selenium — for Hashimoto's specifically

Moderate evidence

Selenium is a cofactor for deiodinase enzymes and has anti-inflammatory effects on thyroid tissue. Multiple RCTs have shown that selenium supplementation reduces TPO antibody levels and thyroid inflammation in Hashimoto's thyroiditis. It does not cure Hashimoto's but reduces the autoimmune attack on the thyroid — potentially slowing disease progression and reducing symptom severity.

Key points

• Reduces TPO antibody levels by 30-50% in RCTs — directly reducing autoimmune thyroid attack

• Reduces thyroid inflammation and may slow disease progression

• Improves quality of life scores in Hashimoto's patients independently of TSH effects

• Safe at supplemental doses — selenomethionine form preferred

How to use this

200µg selenium (selenomethionine form) daily. Takes 3-6 months to see antibody reduction. Do not exceed 400µg daily — selenium toxicity is possible at high doses. Safe to combine with levothyroxine. Retest TPO antibodies after 6 months to confirm response.

🥗

Dietary and lifestyle factors for thyroid health

Moderate evidence

Several dietary factors directly affect thyroid function — both supporting optimal hormone production and potentially worsening autoimmune thyroid disease. Gluten is the most discussed — and the most contested — dietary factor in Hashimoto's.

Key points

• Iodine adequacy — required for thyroid hormone synthesis but excess iodine worsens Hashimoto's. Avoid high-dose iodine supplements.

• Gluten elimination — may reduce thyroid antibodies in women with concurrent coeliac or non-coeliac gluten sensitivity. Evidence is modest but a 3-month trial is reasonable in Hashimoto's.

• Iron adequacy — iron deficiency impairs thyroid peroxidase activity. Check ferritin alongside thyroid function.

• Avoiding raw goitrogenic foods in excess — raw broccoli, kale, and cauliflower in very large amounts can impair thyroid function. Cooking eliminates this effect.

• Managing stress — cortisol elevation suppresses T4-to-T3 conversion and blunts thyroid hormone receptor sensitivity.

How to use this

Ensure iodine through food (dairy, seafood, eggs) rather than supplements. Check ferritin — raise to above 75 µg/L if low. If Hashimoto's, consider a strict gluten-free trial for 3 months and retest antibodies. Manage cortisol through sleep and stress reduction — HPA dysregulation worsens thyroid symptoms.

💊

HRT — and how it interacts with thyroid function

Moderate evidence

For women with both hypothyroidism and perimenopause symptoms, HRT and thyroid treatment work on different but complementary axes. Transdermal estrogen is preferred over oral when on levothyroxine — oral estrogen increases TBG and may require a levothyroxine dose increase. Getting the thyroid right is also important for HRT response — unresolved hypothyroidism blunts the response to HRT, and unresolved menopause symptoms worsen thyroid-related fatigue and brain fog.

Key points

• Transdermal estrogen does not increase TBG — no levothyroxine dose adjustment needed

• Treating the perimenopausal component improves sleep, reduces cortisol, and reduces the HPA dysregulation that worsens T4-to-T3 conversion

• Women with both conditions often find that treating both synergistically resolves symptoms that neither treatment alone fully addressed

How to use this

Use transdermal estrogen (patch or gel) rather than oral — it avoids the TBG increase that requires levothyroxine dose adjustment. If switching from oral to transdermal HRT, recheck thyroid function 6-8 weeks later — levothyroxine dose may need to decrease. Tell your GP/endocrinologist about all hormonal treatments when managing both conditions.

What to say to your doctor

Getting the right tests — not just a TSH screen

"I am in perimenopause and experiencing fatigue, brain fog, and cold intolerance that could be thyroid-related. I would like a full thyroid panel — TSH, free T4, free T3, and TPO antibodies — not just a TSH screen. I would also like to see the actual numbers rather than just whether they are normal."

"My TSH is 2.8 but I remain very symptomatic. I would like to see the free T3 result specifically — I understand that some women have TSH within range but free T3 in the lower quartile, which can produce significant symptoms."

"I have Hashimoto's and remain symptomatic on levothyroxine with TSH within range. I would like to discuss whether T4+T3 combination therapy or desiccated thyroid extract might be appropriate, and a referral to an endocrinologist."

Full doctor conversation guides →

Rose on this

"The thyroid-menopause overlap is genuinely consequential — not a minor academic point. Women who spend years managing 'menopause symptoms' that are actually undiagnosed Hashimoto's are being undertreated for a condition that is damaging their thyroid. And women who are given levothyroxine without proper T3 testing may remain symptomatic while their doctor considers them adequately treated. Get the full panel. Know your numbers. The diagnosis may need to be both — perimenopause and thyroid — treated together."

From Rose

"Getting the thyroid piece right — especially the free T3 — is often what finally shifts the picture for women who have been trying everything and still feeling unwell. It is one more piece of the hormonal puzzle. When all the pieces are addressed together — estrogen, progesterone, thyroid, iron, vitamin D — the cumulative improvement is frequently much greater than any single intervention delivered alone."

What we do not know yet

?Whether treating subclinical hypothyroidism (TSH 4.5-10) in perimenopausal women provides meaningful quality-of-life benefit — RCT data is mixed and current guidelines are conservative, but clinical experience suggests benefit is more common than trials indicate

?The optimal TSH target for perimenopausal women specifically — the general population optimal of 0.5-2.5 has not been validated specifically in this age group and hormonal context

?Whether the gluten-Hashimoto connection is causal or associative — the evidence for gluten elimination reducing antibodies is promising but the mechanism and which women will respond is not yet well characterised

Written by

Rose

Navigating perimenopause · Researcher · Founded rosemyfriend.com

Research basis

PubMed · Cochrane reviews · NICE guidelines · British Menopause Society · The Menopause Society

Read methodology →

Last updated

March 2026

Key sources

Bauer et al. — Thyroid disorders and menopause (Maturitas, 2020)Stagnaro-Green et al. — Thyroid disease in pregnancy and beyond (Thyroid, 2011)Winther et al. — Selenium and thyroid antibodies — RCT (JCEM, 2020)British Thyroid Association — Patient guidance on thyroid testing

Rose provides evidence-graded educational information — not medical advice. Always discuss health decisions with a qualified healthcare provider. Full disclaimer · About Rose